Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

This study has been terminated.

( Study terminated as principal investigator [PI] left the university. )

Study NCT00005984 Information provided by Masonic Cancer Center, University of Minnesota

First Received: July 5, 2000 Last Updated: May 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2005
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)